Impaired proliferative response to B-lymphocyte activators in common variable immunodeficiency

Area of Science:

• Immunology
• Cellular Immunology
• Clinical Immunology

Background:

• Common variable immunodeficiency (CVI) is characterized by defects in humoral immunity.
• Cell-mediated immune responses in CVI patients require further investigation.
• B-lymphocyte function is crucial for adaptive immune responses.

Purpose of the Study:

• To investigate the cell-mediated immune responses in patients with CVI.
• To evaluate the role of B-lymphocyte function in lymphocyte proliferation using microbial activators.
• To explore potential diagnostic tools for primary immunodeficiency diseases.

Main Methods:

• Studied 39 CVI patients' in vitro cell-mediated immune responses.
• Utilized Staphylococcus aureus, Escherichia coli, and Candida albicans extract as microbial activators.
• Assessed lymphocyte proliferative responses and correlated them with serum IgG levels and B-cell numbers.

Main Results:

• CVI patients exhibited significantly depressed lymphocyte proliferative responses compared to controls (P<0.01).
• Responses to microbial activators were dependent on intact B-lymphocyte function.
• Lower serum IgG levels (<125 mg/dl) correlated with markedly reduced lymphocyte responses (P<0.01).
• Depressed responses did not correlate with B-cell numbers, suggesting intrinsic B-lymphocyte deficiency.

Conclusions:

• Cell-mediated immunity is impaired in CVI patients.
• Intrinsic B-lymphocyte deficiency contributes to immune dysfunction in CVI.
• Microbial activators are valuable tools for assessing lymphocyte function in immunodeficiency.